This article is more than 5 years old. Information may no longer be current.
8 guideline recommendations your patients need to know
Click Here to Manage Email Alerts
Providing high-quality, high-value cancer care starts with having the most current information regarding new guidelines and treatment recommendations – and ensuring that your patients are also aware of changes that may impact them. Patients who are well-informed about their conditions and treatment options are more likely to take an active role in managing their own care, and in doing so, become their own advocates and invaluable partners for clinicians.
HemOnc Today offers a brief review of the most recently issued clinical practice guidelines, as well as the latest revisions to preexisting guidelines for the identification, treatment and management of patients.
Guidelines target pulmonary hypertension in patients with sickle cell disease
The American Thoracic Society recently formulated clinical practice guidelines to better identify and manage patients with sickle cell disease who are at increased risk for death from pulmonary hypertension. Read more.
ASCO: SLNB an option for more women with operable breast cancer
ASCO issued expanded recommendations for the appropriate use of sentinel lymph node biopsy as an alternative to axillary lymph node dissection among patients with early-stage breast cancer. Read more.
USPSTF supports BRCA-related cancer screening in women with family history
The US Preventive Services Task Force recommended that primary care physicians screen asymptomatic women with a family history of breast, ovarian, tubal or peritoneal cancers for BRCA1 or BRCA2 mutations. Read more.
USPSTF issues finalized lung cancer screening recommendations
The US Preventive Services Task Force recommended annual lung cancer screening with low-dose CT scans in adults aged 55 to 80 years who are at high risk for lung cancer. Read more.
Guideline recommends HER-2 testing for all invasive breast cancers
ASCO and the College of American Pathologists issued a joint guideline that recommends all patients with newly diagnosed invasive breast cancer be tested for HER-2 status to help guide treatment decisions. Read more.
When to incorporate palliative care into cancer treatment
ASCO recently published a provisional clinical opinion addressing the integration of palliative care in oncologic clinical practice. The statement indicates that palliative care may begin at the time of diagnosis of metastatic or advanced disease. Read more.
When to recommend mammography: NCI, ACS suggest screening at age 40 years
The NCI recommends mammography for women aged at least 40 years. Women in this age group should be screened with mammography every 1 to 2 years. Women aged at least 50 years also should be screened every 1 to 2 years. Read more.
Despite new USPSTF recommendation, men remain favorably inclined to PSA testing
Most men still plan to undergo PSA testing despite recent evidence that suggested the harms outweigh the benefits. Read more.